E-ISSN: 2147-2688
Investigation of Antimicrobial Activity of Tigecycline in Methicillin Resistant Staphylococci Isolated from Hospitalized Patients in Intensive Care Units
PDF
Cite
Share
Request
Original Article
VOLUME: 55 ISSUE: 1
P: 52-55
March 2017

Investigation of Antimicrobial Activity of Tigecycline in Methicillin Resistant Staphylococci Isolated from Hospitalized Patients in Intensive Care Units

Med Bull Haseki 2017;55(1):52-55
DOI: 10.4274/haseki.3190
Emine Küçükateş 1
Nazmi Gültekin 2
1. Istanbul Üniversitesi Kardiyoloji Enstitüsü, Mikrobiyoloji Ve Klinik Mikrobiyoloji Laboratuvari, Istanbul, Türkiye
2. Istanbul Üniversitesi Kardiyoloji Enstitüsü, Kardiyoloji Anabilim Dali, Haseki, Istanbul, Türkiye
No information available.
No information available
Received Date: 21.03.2016
Accepted Date: 12.05.2016
PDF
Cite
Share
Request

ABSTRACT

Aim:

The aim of this study was to evaluate the in vitro antimicrobial efficacy of tigecycline in methicillin-resistant staphylococci isolated from patients hospitalized in intensive care units.

Methods:

We investigated methicillin-resistant staphylococci isolated from blood, wound, urine, catheter tips, endotacheal aspiration fluids (ETA), and sputum specimens of patients hospitalized in the coronary and surgical intensive care units at İstanbul University Cardiology Institute, between June 2014 and December 2015. All staphylococci were identified by the conventional methods and susceptibility testing was performed using Mueller-Hinton Agar by the Kirby-Bauer disc diffusion method.

Results:

Of 67 methicillin-resistant staphylococci, 37 (55.2%) were Staphylococcus aureus (MRSA) and 30 (44.8%) were coagulase negative staphylococci (MRCNS). MRSA were isolated from blood (20), wound (10), ETA (3), urine (2), catheter tips (1) and sputum (1). MRCNS were also identified in blood (20) and wound (10). All staphylococci were susceptible to tigecycline.

Conclusion:

In our study, tigecycline was effective against all methicillin resistant staphylococci. Tigecycline can be an alternative to other drugs against infections caused by methicillin-resistant staphylococci.